Clin Colon Rectal Surg 2014; 27(04): 172-181
DOI: 10.1055/s-0034-1394156
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Biomaterials in the Treatment of Anal Fistula: Hope or Hype?

Daniele Scoglio
1   Department of Surgery, University of Washington Medical Center, Seattle, Washington
,
Avery S. Walker
2   Department of Surgery, Madigan Army Medical Center, Fort Lewis, Washington
,
Alessandro Fichera
1   Department of Surgery, University of Washington Medical Center, Seattle, Washington
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
10. November 2014 (online)

Preview

Abstract

Anal fistula (AF) presents a chronic problem for patients and colorectal surgeons alike. Surgical treatment may result in impairment of continence and long-term risk of recurrence. Treatment options for AFs vary according to their location and complexity. The ideal approach should result in low recurrence rates and minimal impact on continence. New technical approaches involving biologically derived products such as biological mesh, fibrin glue, fistula plug, and stem cells have been applied in the treatment of AF to improve outcomes and decrease recurrence rates and the risk of fecal incontinence. In this review, we will highlight the current evidence and describe our personal experience with these novel approaches.